Ipratropium bromide


Generic Medicine Info
Contraindications
Hypersensitivity to ipratropium, atropine, or its derivatives.
Special Precautions
Patient w/ prostatic hyperplasia/bladder neck obstruction, myasthenia gravis, narrow-angle glaucoma, cystic fibrosis. Pregnancy and lactation. Patient Counselling This drug may cause dizziness, accommodation disorder, mydriasis and blurred vision, if affected, do not drive or operate machinery.
Adverse Reactions
Dry mouth, constipation, tachycardia, palpitations, arrhythmias, nausea and vomiting, dyspepsia, headaches, dizziness, ocular complications (e.g. mydriasis, narrow-angle glaucoma). Rarely, urinary retention, hypersensitivity reactions (e.g. urticaria, angioedema, rash); nasal dryness, irritation and epistaxis.
Potentially Fatal: Paradoxical bronchospasm, anaphylaxis.
Drug Interactions
Additive bronchodilatory effect w/ β-adrenergic drugs and xanthine preparations.
ATC Classification
R01AX03 - ipratropium bromide ; Belongs to the class of other nasal preparations for topical use.
R03BB01 - ipratropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Disclaimer: This information is independently developed by CIMS based on ipratropium bromide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in